Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Age
2–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Polyarticular (both rheumatoid factor positive and rheumatoid factor negative),oligoarticular and extended oligoarticular JIA for ≥3 months meeting the International League of Associations for Rheumatology (ILAR) criteria for Juvenile Idiopathic Arthritis (JIA)
Subjects with Systemic JIA with active arthritis in at least 1 joint but without active systemic features are eligible
≥2 years of age and \<18 years of age prior to the Baseline visit
Body weight ≥10 kg at the Baseline visit
Candidate for chronic NSAID therapy in the Investigator's judgment
You may not be if
Psoriatic arthritis, enthesitis-related arthritis, and undifferentiated arthritis types of JIA
Active systemic features over the prior 12 weeks in children with systemic Juvenile Idiopathic Arthritis (JIA)
Subjects with psoriatic arthritis, enthesitis-related arthritis, and undifferentiated arthritis should be excluded
Subjects with active Systemic JIA should not be enrolled
